A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins
Snehal Nirgude(Children's Hospital of Philadelphia), Bibha Choudhary(Institute of Bioinformatics and Applied Biotechnology)
Cited by 2
Related Papers
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells
|Scientific Reports|2016|79
Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines
|BMC Complementary and Alternative Medicine|2019|62